Prescribers and patients drive maintenance therapy patterns in a community oncology practice: National guidelines versus the real-world experience

Objective: Previous studies have shown that first-line (1L) maintenance therapy (MT) with poly(ADP-ribose) polymerase inhibitors and/or bevacizumab improves outcomes among patients with advanced ovarian cancer (OC); however, these treatments are underutilized. This study aimed to provide a real-worl...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Dana M. Chase, Laura Iadeluca, Jonathan Lim, Wan-Yu Tseng, Purva Bulsara, Gregory Patton
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Elsevier 2024-08-01
Sarja:	Gynecologic Oncology Reports
Aiheet:	Bevacizumab Maintenance therapy Ovarian cancer PARPi Platinum-based chemotherapy
Linkit:	http://www.sciencedirect.com/science/article/pii/S235257892400119X
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!